A new pharmaceutical being developed is offering sufferers of the genetic disease phenylketonuria the hope of being able to eat a normal, protein-rich diet.
A new pharmaceutical being developed is offering sufferers of the genetic disease phenylketonuria the hope of being able to eat a normal, protein-rich diet.